Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Operating Expenses

₹34.79B

Quarterly · Period ending: · INR

RDY logo

RDY Operating Expenses

Latest reported₹34.79B INR
RDY Quarterly Operating Expenses · INR (₹911.79M → ₹34.79B)
High-resolution chart · PNG

RDY operating expenses history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Operating Expenses — Quarterly (INR)
Period endingOperating Expenses (INR)
34,791,177,000
33,741,924,000
32,568,000,000
30,627,000,000
31,152,000,000
29,616,000,000
30,332,000,000
30,218,000,000
28,419,000,000
26,524,000,000
24,936,000,000
293,220,673
21,917,000,000
283,998,084
23,602,000,000
268,506,580
13,815,000,000
265,813,146
19,355,000,000
275,526,718
19,121,000,000
253,301,829
24,339,000,000
211,255,460
16,647,000,000
16,199,000,000
212,085,471
20,318,000,000
11,920,000,000
15,708,000,000
15,023,000,000
16,323,000,000
16,028,000,000
16,248,000,000
16,402,000,000
15,099,000,000
16,640,000,000
15,047,000,000
16,128,000,000
16,709,000,000
16,986,000,000
16,204,000,000
16,011,000,000
15,215,000,000
15,209,000,000
15,101,000,000
15,125,000,000
14,521,000,000
14,329,000,000
14,066,000,000
13,275,000,000
12,108,000,000
10,876,000,000
9,417,000,000
10,356,000,000
9,375,000,000
9,620,000,000
8,760,000,000
9,028,000,000
8,460,000,000
7,766,000,000
7,106,000,000
7,481,000,000
6,759,000,000
6,289,000,000
6,527,000,000
6,152,000,000
6,175,000,000
6,912,000,000
6,215,000,000
6,519,000,000
6,198,015,000
5,965,000,000
5,751,743,012
7,312,211,637
4,480,619,181
4,011,301,749
6,337,482,977
4,650,942,933
4,399,785,798
4,279,189,692
3,185,229,083
2,267,459,090
2,273,965,880
2,632,086,903
3,419,793,407
2,356,260,822
2,491,880,753
2,580,965,433
2,806,632,172
2,099,178,061
1,964,485,109
1,816,279,151
2,128,861,998
1,745,131,869
1,717,729,513
1,281,781,062
1,431,631,192
1,267,084,308
1,075,000,195
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.